Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Growth

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -76.6411.90-35.99-579.49-62.36

What is the latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL is -76.64 based on Mar2026 Standalone results.
Year Core EBITDA Growth
Mar2026-76.64
Mar202511.90
Mar2024-35.99
Mar2023-579.49
Mar2022-62.36

How is Core EBITDA Growth of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Growth % Change
Mar2026 -76.64
Negative
Mar2025 11.9
Positive
Mar2024 -35.99
Negative
Mar2023 -579.49
Negative
Mar2022 -62.36 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Growth ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹198.3 Cr 6.4% 15.9% -51% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

6.4%

15.9%

-51%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses